BioSpace News Archive

Drug Farm Doses First Patient in Part 3 of Phase 1 Chronic Hepatitis B Trial

Drug Farm, a clinical-stage biopharmaceutical company, announced that it has dosed the first chronic hepatitis B patient in Part 3 of its Phase 1 clinical trial.

September 26, 2023

·

2 min read

Business

Outstanding Traditional Chinese Medicine Vitiligo Treatment Institution Establishes Itself in Shanghai, Aiming to Provide Specialized Treatment Solutions to More International Patients

Recently has unveiled a remarkable announcement: the inauguration of the Huahai Institute of Vitiligo Research in Shanghai.

September 26, 2023

·

5 min read

Genetown

Revvity Expands Access to Base Editing Technology With Aim to Accelerate Discovery to Cure

Revvity, Inc., unveils its groundbreaking Pin-point™ base editing platform reagents, providing researchers with unparalleled access to implement the advanced gene editing technique in their preclinical laboratories.

September 26, 2023

·

4 min read

Biotech Bay

Moon Surgical Announces First Clinical Cases in the U.S. Using Maestro System

Moon Surgical, a French-American pioneer in collaborative robotics, announced that Baptist Health performed the first clinical procedures in the United States using the Maestro System.

September 26, 2023

·

3 min read

AM-Pharma Announces Updated Clinical Development Strategy

AM-Pharma B.V. announced an updated clinical development strategy to evaluate ilofotase alfa in two indications.

September 26, 2023

·

6 min read

Biotech Beach

Rockley Photonics Advances Non-Invasive Blood Glucose Monitoring

Rockley Photonics continues to make rapid progress towards noninvasive glucose sensing using its proprietary silicon photonics platform.

September 26, 2023

·

3 min read

Genetown

Alzheon To Present Pivotal Program of Oral ALZ-801/Valiltramiprosate at Singularity Conference, Goldman Sachs Alzheimer’s Disease Day, and BIO Investor Forum

Alzheon, Inc., a clinical-stage biopharmaceutical company developing a portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s disease and related neurodegenerative disorders, announced that the company will be presenting at upcoming industry and investor conferences.

September 26, 2023

·

8 min read

Biotech Bay

Mission Bio Announces Launch of Single-Cell Measurable Residual Disease (MRD) Assay Aimed to Advance Personalized Healthcare for Blood Cancer Patients

Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, announced the commercial launch of the Tapestri® Single-cell MRD (scMRD) AML Multiomics Assay.

September 26, 2023

·

4 min read

Business

Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation

Melt Pharmaceuticals, Inc. today announced it recently entered into an exclusive development and license agreement with Catalent, the global leader in enabling the development and supply of better treatments across multiple modalities.

September 26, 2023

·

3 min read

BioCapital

OS Therapies Announces Full Enrollment in PhIIb Clinical Trial AOST-2121 in Recurred, Resected Osteosarcoma with OST-HER2 (Listeria monocytogenes) for Delay or Prevention of Recurrence

OS Therapies Announces Full Enrollment in PhIIb Clinical Trial AOST-2121 in Recurred, Resected Osteosarcoma with OST-HER2 ( Listeria monocytogenes ) for Delay or Prevention of Recurrence.

September 26, 2023

·

2 min read